Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT. Papadimitraki ED, et al. Among authors: raptopoulou a. Arthritis Rheum. 2006 Nov;54(11):3601-11. doi: 10.1002/art.22197. Arthritis Rheum. 2006. PMID: 17075805 Free article.
Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures.
Nakou M, Knowlton N, Frank MB, Bertsias G, Osban J, Sandel CE, Papadaki H, Raptopoulou A, Sidiropoulos P, Kritikos I, Tassiulas I, Centola M, Boumpas DT. Nakou M, et al. Among authors: raptopoulou a. Arthritis Rheum. 2008 Nov;58(11):3541-9. doi: 10.1002/art.23961. Arthritis Rheum. 2008. PMID: 18975309 Free PMC article.
Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
Bertsias GK, Nakou M, Choulaki C, Raptopoulou A, Papadimitraki E, Goulielmos G, Kritikos H, Sidiropoulos P, Tzardi M, Kardassis D, Mamalaki C, Boumpas DT. Bertsias GK, et al. Among authors: raptopoulou a. Arthritis Rheum. 2009 Jan;60(1):207-18. doi: 10.1002/art.24227. Arthritis Rheum. 2009. PMID: 19116915 Free article.
Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response.
Nakou M, Katsikas G, Sidiropoulos P, Bertsias G, Papadimitraki E, Raptopoulou A, Koutala H, Papadaki HA, Kritikos H, Boumpas DT. Nakou M, et al. Among authors: raptopoulou a. Arthritis Res Ther. 2009;11(4):R131. doi: 10.1186/ar2798. Epub 2009 Aug 28. Arthritis Res Ther. 2009. PMID: 19715572 Free PMC article.
An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab.
Sidiropoulos PI, Siakka P, Raptopoulou A, Mamoulaki M, Choulaki C, Koutala H, Kouroumali H, Kritikos H, Boumpas DT. Sidiropoulos PI, et al. Among authors: raptopoulou a. Ann Rheum Dis. 2006 Apr;65(4):538-41. doi: 10.1136/ard.2005.036152. Epub 2005 Aug 26. Ann Rheum Dis. 2006. PMID: 16126800 Free PMC article. Clinical Trial.
Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance.
Stagakis I, Bertsias G, Karvounaris S, Kavousanaki M, Virla D, Raptopoulou A, Kardassis D, Boumpas DT, Sidiropoulos PI. Stagakis I, et al. Among authors: raptopoulou a. Arthritis Res Ther. 2012 Jun 12;14(3):R141. doi: 10.1186/ar3874. Arthritis Res Ther. 2012. PMID: 22691241 Free PMC article. Clinical Trial.
18 results